Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

Since 2013 next-generation sequencing (NGS) targeting genes mutated in diffuse gliomas is part of routine diagnostics in our institute. In the present report, we evaluate the use of this custom tailored NGS platform on 434 samples. The NGS panel assesses mutations in ATRX, CIC, EGFR, FUBP1, NOTCH1,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Acta Neuropathol Commun
Egile Nagusiak: Synhaeve, Nathalie E., van den Bent, Martin J., French, Pim J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Verdijk, R., Dirven, Clemens M. F., Dubbink, Hendrikus J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251173/
https://ncbi.nlm.nih.gov/pubmed/30470264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-018-0633-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak